03/12/2026
Regenerative medicine is exploding in podiatry and with all the buzz, it’s not always clear who to trust.
We’re seeing more companies market tissue products as “compliant” 361 HCT/Ps — but many don’t meet the regulatory standards required.
And here’s the truth too few people are saying:
A study does not make a noncompliant product compliant. Regulatory protection comes from sourcing, processing, labeling, and manufacturing — not from research papers or marketing claims.
AIMx works exclusively with manufacturers that meet strict FDA, cGTP, cGMP, and AATB standards because protecting your patients and your license isn’t optional.
If you’re navigating the regenerative landscape or evaluating a new vendor, AIMx created a practical guide to help physicians ask the right questions — no pressure, just clarity.